(Q45242443)

11 December 2017

title

Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis (English)

1 reference

11 December 2017

3

Ruth Arnon

1 reference

11 December 2017

1

Rina Aharoni

1 reference

11 December 2017

Basak Kayhan

2

1 reference

11 December 2017

language of work or name

1 reference

1 February 2005

1 reference

Inflammatory Bowel Diseases

11 December 2017

published in

1 reference

11 December 2017

volume

11

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

106-115

1 reference

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Biologic therapy of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Immunotherapy of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells--specificity and promiscuity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Oral tolerance in the treatment of inflammatory autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Copolymer 1 inhibits manifestations of graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factorin situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200502000-00003

10.1097/00054725-200502000-00003

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference